Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Exelixis- Inc. (EXEL)

26.98 -0.19 (-0.70%)

10/23/2017  4:00pm

Open:

27.47

Pre. Close:

27.17

High:

27.66

Low:

26.90

Volume:

2,054,013

Market Cap:

7.93B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

28.28 - 28.79

28.79 - 29.23

Low:

25.34 - 26.08

26.08 - 26.71

Close:

25.99 - 27.14

27.14 - 28.13

Technical analysis  (as of: 2017-10-23 4:39:35 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 33.80     One year: 37.96

Support:

Support1: 23.18    Support2: 19.29

Resistance:

Resistance1: 28.94    Resistance2: 32.50

Pivot:

26.29

Moving Averages:

MA(5): 27.49     MA(20): 25.72

MA(100): 25.46     MA(250): 21.57

MACD:

MACD(12,26): 0.34     Signal(12,26,9): 0.08

%K %D:

%K(14,3): 39.14     %D(3): 42.59

RSI:

RSI(14): 53.90

52-Week:

High: 32.50  Low: 10.04  Change(%): 138.8

Average Vol(K):

3-Month: 378393  10-Days 560963

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EXEL has closed below upper band by 37.0%. Bollinger Bands are 29.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 21 Oct 2017 14:37:30 GMT
The case for Intra-Cellular Therapies

Mon, 23 Oct 2017 11:37:30 GMT
Exelixis - Elucidating The Ramifications Of The Celestial Trial

Mon, 16 Oct 2017 16:52:30 GMT
Why Exelixis, Inc. Rose Higher Today

Thu, 05 Oct 2017 14:26:15 GMT
The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September

Sat, 30 Sep 2017 14:37:30 GMT
The case for Immunogen

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

268.92

% Held by Insiders

5.93

% Held by Institutions

81.07

Shares Short (K)

15550

Shares Short Prior Month (K)

15900

Stock Financials

EPS

0.200

EPS Est. Current Year

0.280

EPS Est. Next Year

0.670

EPS Est. Next Quarter

0.090

Forward EPS

0.660

Book Value (p.s.)

0.510

PEG Ratio

2.13

Profit Margin

18.21

Operating Margin

29.47

Return on Assets (ttm)

11.9

Return on Equity (ttm)

Qtrly Rev. Growth

173.1

Gross Profit (p.s.)

0.629

Sales Per Share

EBITDA (p.s.)

0.324

Qtrly Earnings Growth

Operating Cash Flow (M)

149.61

Levered Free Cash Flow (M)

48.71

FoxReading.com

Valuation

P/E

134.90

P/E Growth Ratio

-0.01

P/BV

52.90

P/S

7017187328.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.